compliance
$1.3 Billion/Month Later: What Cannabis Banking Has Really Taught Us
A decade ago, most banks wouldn’t touch a cannabis business. Whenever banking access came up, the discussion stopped almost immediately. People said it was too risky, too unclear, or that the timing just wasn’t right. Today, Green Check has over 180 financial institutions across the U.S. that actively serve more than 17,000 licensed operators. Together, […]
Trump Reschedules Cannabis!
The moment many in the cannabis industry have been waiting for has finally arrived. Operators, investors, and advocates are cautiously celebrating President Trump’s executive order directing the Department of Justice to finalize the rescheduling of cannabis to Schedule III, an action many hope is a stepping stone toward full federal descheduling. Full descheduling would free […]
Untangling Another Hemp Loophole, International Trade, and Supply Chain Liability
As the industry clings to the hope of rescheduling, legal chaos continues to intensify after Congress moved to close the hemp loophole. The new language, set to take effect next October, has many hemp beverage and edible companies scrambling for a Plan B. While the intent was to rein in intoxicating cannabinoids like THCV, the […]
Cannabis Banking Today: Navigating Verification, Compliance, and Regulatory Change
Banking for cannabis businesses has come a long way. Ten years ago, most banks wouldn’t even consider it. Conversations would stop almost as soon as they began. “Too risky,” they’d say. “Too unclear.” Or, “Maybe someday, but not now.” Fast forward to today, and Green Check Verified works with more than 180 financial institutions across […]
International Trade and Cannabis Decontamination Considerations
With shifting perceptions, economic incentives, and the evolution of international regulatory frameworks, more countries around the world are starting to embrace legal cannabis for its medical and recreational uses. One of the hotspots of legalization remains the European Union, where countries like Malta and Luxembourg have legalized cannabis for adult use, and Switzerland and the […]
MariMed Is Raising The Bar For Cannabis Quality
MariMed, one of the nation’s leading multi-state cannabis operators, began in the medical cannabis market and expanded into adult-use as states legalized. Through this growth, the company has remained true to its “medical-first” approach, ensuring that product quality, safety, and consistency remain at the core of its operations. Under the leadership of Chief Commercial Officer […]
Why Dispensaries Can’t Afford to Neglect HR Compliance
Most cannabis dispensaries are small businesses. That often means they operate on tight margins and require employees to take on roles outside their typical job descriptions. It’s common for owners or general managers to handle HR and payroll functions themselves. What begins as an understandable cost-saving measure, however, can quickly become disastrous. As federal rescheduling draws near, […]
Target Just Opened the Door — Is Your Brand Compliance-Ready for Mass Retailers?
Target’s decision to start selling hemp-derived THC beverages marks a major milestone for the cannabis industry and a reality check for brands hoping to follow. Selling into mass retail is not just about scaling production or packaging appeal. It requires proving that your product meets the same safety and manufacturing standards as food, pharma, and […]
How Cannabis Moves Around the World: Inside the Global Supply Chain
Global cannabis trade is well underway as legalized countries move forward to establish a supply chain infrastructure in a newly formed and rapidly evolving industry. At the forefront of transportation logistics is Cannabilog, an Israeli company led by pharmaceutical industry veteran Yoram Eshel. In an interview, he shared his playbook for building a compliant, efficient, […]
Why America Needs a National Medical Cannabis Program, Now
The cannabis industry’s fragmented foundation is creating a host of problems tied to the lack of federal legalization. Many experts believe that without a national medical cannabis framework, the future of cannabis as a medicine in America could leave patients unprotected, research underfunded, and the industry consumed by unchecked commercial interests. Few voices have been […]